Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Statins. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN103408580B details a safer statins intermediate synthesis route eliminating butyllithium. This offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN102978249A details a single-enzyme biocatalytic route for statin intermediates. Achieve >99% ee with simplified workup and reduced manufacturing costs.
Patent CN103420837A reveals a cobalt-catalyzed hydroesterification route for chiral 4-chloro-3-hydroxybutyrate, offering high atom economy and supply chain reliability for pharmaceutical manufacturers.
Novel dehalogenase method for pitavastatin intermediates offers high purity and yield. Reduces environmental impact and enhances supply chain reliability for pharmaceutical manufacturers globally.
Patent CN107673982A details green synthesis for Pitavastatin intermediate. Offers high purity, cost reduction in API intermediate manufacturing, and scalable supply chain reliability.